GPC3 and neoplasm: GPC3-AS1 promoted hepatocellular carcinoma progression via epigenetically activating GPC3, and was correlated with α-fetoprotein level, tumor size, microvascular invasion, tumor encapsulation, cancer stage, and worse prognosis.